Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115996242 | 11599624 | 2 | F | 20150913 | 20160131 | 20151006 | 20160721 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-068238 | BRISTOL MYERS SQUIBB | 1.00 | DY | Y | 0.92000 | KG | 20160721 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115996242 | 11599624 | 1 | PS | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | 1 | Transplacental | 400 MG, QD | 41200 | MG | U | 21567 | 400 | MG | QD | ||||
| 115996242 | 11599624 | 2 | SS | NORVIR | RITONAVIR | 1 | Transplacental | 100 MG, QD | 10300 | MG | U | 0 | 100 | MG | QD | ||||
| 115996242 | 11599624 | 3 | SS | TRUVADA | EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | Transplacental | 500 MG, QD | 51500 | MG | U | 0 | 500 | MG | QD | ||||
| 115996242 | 11599624 | 4 | SS | COCAINE | COCAINE | 1 | Transplacental | U | 0 | ||||||||||
| 115996242 | 11599624 | 5 | SS | METRONIDAZOLE. | METRONIDAZOLE | 1 | Transplacental | U | 0 | ||||||||||
| 115996242 | 11599624 | 6 | SS | BETAMETHASONE. | BETAMETHASONE | 1 | Transplacental | 1 DF, UNK | Y | 0 | 1 | DF |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 115996242 | 11599624 | 1 | Product used for unknown indication |
| 115996242 | 11599624 | 2 | Product used for unknown indication |
| 115996242 | 11599624 | 3 | Product used for unknown indication |
| 115996242 | 11599624 | 4 | Product used for unknown indication |
| 115996242 | 11599624 | 5 | Product used for unknown indication |
| 115996242 | 11599624 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 115996242 | 11599624 | CA |
| 115996242 | 11599624 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 115996242 | 11599624 | Foetal exposure during pregnancy | |
| 115996242 | 11599624 | Patent ductus arteriosus | |
| 115996242 | 11599624 | Premature baby |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 115996242 | 11599624 | 1 | 20150603 | 20150913 | 0 | |
| 115996242 | 11599624 | 2 | 20150603 | 20150913 | 0 | |
| 115996242 | 11599624 | 3 | 20150603 | 20150913 | 0 | |
| 115996242 | 11599624 | 6 | 20150912 | 20150913 | 0 |